Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

THURSDAY, Jan. 23, 2025 -- Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events...

Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue...

Patients with atrial fibrillation are often prescribed blood thinners, or medlinkanticoagulants/medlink, to lower their medlinkstroke risk/medlink,

Ascletis Pharma Inc., an innovative R&D driven biotech, announces today positive topline results from its US single ascending dose (SAD) study...

Microbial cell-free DNA (mcfDNA) testing shows the potential to offer a less invasive and faster alternative to identify microbial infections in the...

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with added antitumor effects...

Exelixis, Inc., a globally ambitious oncology company, announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients...

A recent study has uncovered an intriguing relationship between sugar consumption and cardiovascular disease risk. While eating sugary treats in...